SNA
56
-2
HP
34
-10
RRC
58
6
SLB
44
3
PX
53
-3
WMB
60
2
ICE
55
2
DIS
68
-2
UNM
70
3
KLAC
56
11
DVA
65
3
BBY
46
-2
CCI
20
-11
ACN
50
-6
NOV
47
2
CHD
32
-2
EQT
50
3
JWN
60
-9
SYY
41
-2
NI
67
2
SNA
56
-2
HP
34
-10
RRC
58
6
SLB
44
3
PX
53
-3
WMB
60
2
ICE
55
2
DIS
68
-2
UNM
70
3
KLAC
56
11
DVA
65
3
BBY
46
-2
CCI
20
-11
ACN
50
-6
NOV
47
2
CHD
32
-2
EQT
50
3
JWN
60
-9
SYY
41
-2
NI
67
2
Financhill
Back

Entera Bio 10K Form

Sell
48

ENTX
Entera Bio

Last Price:
$2.18
Seasonality Move:
78.56%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ENTX News And Ratings

See the #1 stock for the next 7 days that we like better than ENTX

ENTX Financial Statistics

Sales & Book Value

Annual Sales: $134K
Cash Flow: $-2.2M
Price / Cash Flow: 0
Annual Sales: $0.18
Price / Book: 11.42

Profitability

EPS (TTM): -0.26000
Net Income (TTM): $-9.2M
Gross Margin: $0
Return on Equity: -113.4%
Return on Assets: -94.92%

Entera Bio Earnings Forecast

Key Entera Bio Financial Ratios

  • The Selling, General & Administrative Expenses for ENTX have been equal to 5,412.69% of Gross Profit Margin.
  • The Interest Expense is -0.25% of Operating Income.
  • Per Share Earnings over the last 9 years have been positive in 5 years.

Entera Bio Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ENTX
CUSIP: M40527
Website: enterabio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 6.61
Quick Ratio: 6.26

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ENTX Technical Analysis vs Fundamental Analysis

Sell
48
Entera Bio (ENTX) is a Sell

Is Entera Bio a Buy or a Sell?

  • Entera Bio stock is rated a Sell
    The current Entera Bio [ENTX] share price is $2.18. The Score for ENTX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.